President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Fifteen prescription medications will be the focus of federal price negotiations that could lower prices for Medicare patients.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

Medicare wants to negotiate lower prices for Eli Lilly's GLP-1 drug Trulicity and AbbVie's Botox in its next round of ...

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...